{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T10:35:31Z","timestamp":1792751731079,"version":"4.5.0"},"reference-count":107,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Emerging infectious diseases are caused by unpredictable viruses with the dangerous potential to trigger global pandemics. These viruses typically initiate infection by utilizing the anionic structures of host cell surface receptors to gain entry. Lactoferrin (Lf) is a multifunctional glycoprotein with multiple properties such as antiviral, anti-inflammatory and antioxidant activities. Due to its cationic structure, Lf naturally interacts with certain host cell receptors, such as heparan sulfate proteoglycans, as well as viral particles and other receptors that are targeted by viruses. Therefore, Lf may interfere with virus-host cell interactions by acting as a receptor competitor for viruses. Herein we summarize studies in which this competition was investigated with SARS-CoV-2, Zika, Dengue, Hepatitis and Influenza viruses <jats:italic>in vitro<\/jats:italic>. These studies have demonstrated not only Lf\u2019s competitive properties, but also its potential intracellular impact on host cells, such as enhancing cell survival and reducing infection efficiency by inhibiting certain viral enzymes. In addition, the immunomodulatory effect of Lf is highlighted, as it can influence the activity of specific immune cells and regulate cytokine release, thereby enhancing the host\u2019s response to viral infections. Collectively, these properties promote the potential of Lf as a promising candidate for research in viral infectious diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2024.1402135","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:18:09Z","timestamp":1731651489000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["The potential of lactoferrin as antiviral and immune-modulating agent in viral infectious diseases"],"prefix":"10.3389","volume":"15","author":[{"given":"Furkan","family":"Eker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Duman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melih","family":"Ert\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sercan","family":"Karav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2006.01194.x","article-title":"Emerging viral diseases and infectious disease risks","volume":"12","author":"Tapper","year":"2006","journal-title":"Haemophilia"},{"key":"B2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cnur.2019.02.006","article-title":"Emerging infectious diseases","volume":"54","author":"McArthur","year":"2019","journal-title":"Nurs Clinics North America"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-005-5368-9","article-title":"Molecular structure, binding properties and dynamics of lactoferrin","volume":"62","author":"Baker","year":"2005","journal-title":"Cell Mol Life Sci"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2017.1381583","article-title":"Lactoferrin: Structure, function, denaturation and digestion","volume":"59","author":"Wang","year":"2019","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1888660","article-title":"The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor","volume":"10","author":"Hu","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu12092562","article-title":"Lactoferrin from bovine milk: A protective companion for life","volume":"12","author":"Superti","year":"2020","journal-title":"Nutrients"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/IJMS18040870","article-title":"Studying lactoferrin N-glycosylation","volume":"18","author":"Karav","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/10942912.2019.1666137","article-title":"Lactoferrin (LF): a natural antimicrobial protein","volume":"22","author":"Niaz","year":"2019","journal-title":"Int J Food Prop"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2018.01.002","article-title":"Multifunctional capacity and therapeutic potential of lactoferrin","volume":"195","author":"Moreno-Exp\u00f3sito","year":"2018","journal-title":"Life Sci"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2023.1214514\/BIBTEX","article-title":"Bovine colostrum and its potential contributions for treatment and prevention of COVID-19","volume":"14","author":"Duman","year":"2023","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(01)00146-2","article-title":"Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts","volume":"51","author":"Andersen","year":"2001","journal-title":"Antiviral Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/J.ANTIVIRAL.2004.05.002","article-title":"Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo","volume":"63","author":"Beljaars","year":"2004","journal-title":"Antiviral Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2021.685218\/BIBTEX","article-title":"Lactoferrin retargets human adenoviruses to TLR4 to induce an abortive NLRP3-associated pyroptotic response in human phagocytes","volume":"12","author":"Ch\u00e9neau","year":"2021","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/J.VIROL.2008.06.017","article-title":"Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein","volume":"379","author":"Chien","year":"2008","journal-title":"Virology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANTIVIRAL.2006.09.002","article-title":"Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides","volume":"73","author":"Ammendolia","year":"2007","journal-title":"Antiviral Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2021.1895063","article-title":"Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance","volume":"62","author":"Sienkiewicz","year":"2022","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2016.02.071","article-title":"Overview of lactoferrin as a natural immune modulator","volume":"173","author":"Legrand","year":"2016","journal-title":"J Pediatr"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/ANTIBIOTICS13030251","article-title":"Antimicrobial properties of colostrum and milk","volume":"13","author":"Eker","year":"2024","journal-title":"Antibiotics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/FNUT.2021.651721","article-title":"Bovine colostrum and its potential for human health and nutrition","volume":"8","author":"Arslan","year":"2021","journal-title":"Front Nutr"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/J.1440-1746.2007.04858.X","article-title":"Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin","volume":"22","author":"Kaito","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.1018336","article-title":"Lactoferrin: A glycoprotein that plays an active role in human health","volume":"9","author":"Cao","year":"2023","journal-title":"Front Nutr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.biochi.2008.05.006","article-title":"A structural framework for understanding the multifunctional character of lactoferrin","volume":"91","author":"Baker","year":"2009","journal-title":"Biochimie"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/srep10729","article-title":"The protective effect of lactoferrin on ventral mesencephalon neurons against MPP+ is not connected with its iron binding ability","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.07.020","article-title":"Lactoferrin: structure, function and applications","volume":"33","author":"Gonz\u00e1lez-Ch\u00e1vez","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2023.2207650","article-title":"Lactoferricin, an antimicrobial motif derived from lactoferrin with food preservation potential","volume":"64","author":"Wu","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/MOLECULES25245763","article-title":"Lactoferrin and its derived peptides: an alternative for combating virulence mechanisms developed by pathogens","volume":"25","author":"Zarzosa-Moreno","year":"2020","journal-title":"Molecules"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/PHARMACEUTICS15041056","article-title":"Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense","volume":"15","author":"Ohradanova-Repic","year":"2023","journal-title":"Pharmaceutics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1139\/o11-071","article-title":"A structural perspective on lactoferrin function","volume":"90","author":"Baker","year":"2012","journal-title":"Biochem Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nchembio.1416","article-title":"The role of iron and reactive oxygen species in cell death","volume":"10","author":"Dixon","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15011003","article-title":"Lactoferrin directly scavenges hydroxyl radicals and undergoes oxidative self-degradation: A possible role in protection against oxidative DNA damage","volume":"15","author":"Ogasawara","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/foods12102073","article-title":"Dairy by-products and lactoferrin exert antioxidant and antigenotoxic activity on intestinal and hepatic cells","volume":"12","author":"Abad","year":"2023","journal-title":"Foods"},{"key":"B32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.antiviral.2014.08.012","article-title":"The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein","volume":"111","author":"Picard-Jean","year":"2014","journal-title":"Antiviral Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2014.08.003","article-title":"Lactoferrin for prevention of common viral infections","volume":"20","author":"Wakabayashi","year":"2014","journal-title":"J Infection Chemotherapy"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-022-00458-6","article-title":"Molecular mimicry of the receptor-binding domain of the SARS-CoV-2 spike protein: from the interaction of spike-specific antibodies with transferrin and lactoferrin to the antiviral effects of human recombinant lactoferrin","volume":"36","author":"Sokolov","year":"2023","journal-title":"BioMetals"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2023.125552","article-title":"Inhibitory effect of lactoferrin-coated zinc nanoparticles on SARS-CoV-2 replication and entry along with improvement of lung fibrosis induced in adult male albino rats","volume":"245","author":"El-Fakharany","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.28281","article-title":"Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model","volume":"95","author":"He","year":"2023","journal-title":"J Med Virol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"105805","DOI":"10.1016\/j.idairyj.2023.105805","article-title":"Bovine lactoferrin suppresses the cathepsin-dependent pathway of SARS-CoV-2 entry in vitro","volume":"148","author":"Kobayashi-Sakamoto","year":"2024","journal-title":"Int Dairy J"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/PH16101352","article-title":"Inhibition of SARS-coV-2 infection in vero cells by bovine lactoferrin under different iron-saturation states","volume":"16","author":"Alves","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B39","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1002\/hep.25501","article-title":"Role of low-density lipoprotein receptor in the hepatitis C virus life cycle","volume":"55","author":"Albecka","year":"2012","journal-title":"Hepatology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.000849","article-title":"Bovine lactoferrin activity against chikungunya and zika viruses","volume":"98","author":"Carvalho","year":"2017","journal-title":"J Gen Virol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10719-021-10029-5","article-title":"Role of sialylated glycans on bovine lactoferrin against influenza virus","volume":"38","author":"Wang","year":"2021","journal-title":"Glycoconj J"},{"key":"B42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/v11010051","article-title":"Bovine lactoferrin prevents influenza a virus infection by interfering with the fusogenic function of viral hemagglutinin","volume":"11","author":"Superti","year":"2019","journal-title":"Viruses"},{"key":"B43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10534-010-9323-3","article-title":"Bovine lactoferrin inhibits Influenza A virus induced programmed cell death in vitro","author":"Pietrantoni","year":"2010","journal-title":"BioMetals"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1179\/2047773212Y.0000000004","article-title":"Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus","volume":"106","author":"Ammendolia","year":"2012","journal-title":"Pathog Glob Health"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1139\/o11-072","article-title":"Bovine lactoferrin: Involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection","volume":"90","author":"Pietrantoni","year":"2012","journal-title":"Biochem Cell Biol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/1472-6882-14-219","article-title":"Screening the anti infectivity potentials of native N- and C-lobes derived from the camel lactoferrin against hepatitis C virus","volume":"14","author":"Redwan","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-10-199","article-title":"Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study","volume":"10","author":"El-Fakharany","year":"2013","journal-title":"Virol J"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/nu14081561","article-title":"Inhibition of in vitro infection of hepatitis B virus by human breastmilk","volume":"14","author":"Luo","year":"2022","journal-title":"Nutrients"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/JMV.23549","article-title":"Characterization of the anti-HBV activity of HLP1\u201323, a human lactoferrin-derived peptide","volume":"85","author":"Florian","year":"2013","journal-title":"J Med Virol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.7717\/PEERJ.17302\/SUPP-2","article-title":"Effect of iron saturation of bovine lactoferrin on the inhibition of hepatitis B virus in vitro","volume":"12","author":"Zhou","year":"2024","journal-title":"PeerJ"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3390\/v13050800","article-title":"Structural insight into non-enveloped virus binding to glycosaminoglycan receptors: A review","volume":"13","author":"Sorin","year":"2021","journal-title":"Viruses"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/cshperspect.a004952","article-title":"Heparan sulfate proteoglycans","volume":"3","author":"Sarrazin","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01221","article-title":"The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria","volume":"11","author":"Kell","year":"2020","journal-title":"Front Immunol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/v11070596","article-title":"Heparan sulfate proteoglycans and viral attachment: True receptors or adaptation bias","volume":"11","author":"Cagno","year":"2019","journal-title":"Viruses"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1204149","article-title":"Lactoferrin: neuroprotection against Parkinson\u2019s disease and secondary molecule for potential treatment","volume":"15","author":"Eker","year":"2023","journal-title":"Front Aging Neurosci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.74.082803.133354","article-title":"Structure and physiologic function of the low-density lipoprotein receptor","volume":"74","author":"Jeon","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.10845","article-title":"Lactoferrin induces tropoelastin expression by activating the lipoprotein receptor-related protein 1-mediated phosphatidylinositol 3-kinase\/Akt pathway in human dermal fibroblasts","volume":"41","author":"Ryu","year":"2017","journal-title":"Cell Biol Int"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18091957","article-title":"Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN","volume":"18","author":"Chen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02727-13","article-title":"Hepatitis C virus stimulates low-density lipoprotein receptor expression to facilitate viral propagation","volume":"88","author":"Syed","year":"2014","journal-title":"J Virol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2021.05.002","article-title":"Evidence of a putative glycosaminoglycan binding site on the glycosylated SARS-CoV-2 spike protein N-terminal domain","volume":"19","author":"Schuurs","year":"2021","journal-title":"Comput Struct Biotechnol J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10534-022-00427-z","article-title":"An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection","volume":"36","author":"Rosa","year":"2023","journal-title":"BioMetals"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.71.8.5997-6002.1997","article-title":"Hepatitis C virus envelope proteins bind lactoferrin","volume":"71","author":"Yi","year":"1997","journal-title":"J Virol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302267200","article-title":"Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate","volume":"278","author":"Barth","year":"2003","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00558-3","article-title":"Natural killer cells in antiviral immunity","volume":"22","author":"Bj\u00f6rkstr\u00f6m","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00930","article-title":"Developmental and functional control of natural killer cells by cytokines","volume":"8","author":"Wu","year":"2017","journal-title":"Front Immunol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12928","article-title":"Defining the role of NK cells during dengue virus infection","volume":"154","author":"Mathew","year":"2018","journal-title":"Immunology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22115799","article-title":"The immunological role of the placenta in sars-cov-2 infection\u2014viral transmission, immune regulation, and lactoferrin activity","volume":"22","author":"Bukowska-O\u015bko","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114513004315","article-title":"Bovine lactoferrin ingestion protects against inflammation via IL-11 induction in the small intestine of mice with hepatitis","volume":"111","author":"Kuhara","year":"2014","journal-title":"Br J Nutr"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.10.067","article-title":"Lactoferrin acts as an adjuvant during influenza vaccination of neonatal mice","volume":"467","author":"Sherman","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2012.12.006","article-title":"The clinical efficacy of a bovine lactoferrin\/whey protein Ig-rich fraction (Lf\/IgF) for the common cold: A double blind randomized study","volume":"21","author":"Vitetta","year":"2013","journal-title":"Complement Ther Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/nu13020328","article-title":"Protective effects of lactoferrin against sars-cov-2 infection in vitro","volume":"13","author":"Salaris","year":"2021","journal-title":"Nutrients"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/FOODS12224068\/S1","article-title":"Optimum fermentation conditions for bovine lactoferricin-lactoferrampin-encoding limosiLactobacillus reuteri and regulation of intestinal inflammation","volume":"12","author":"Xie","year":"2023","journal-title":"Foods"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114519000485","article-title":"Porcine lactoferrin-derived peptide LFP-20 modulates immune homoeostasis to defend lipopolysaccharide-triggered intestinal inflammation in mice","volume":"121","author":"Zong","year":"2019","journal-title":"Br J Nutr"},{"key":"B74","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/J.BCP.2016.01.009","article-title":"Porcine lactoferrin-derived peptide LFP-20 protects intestinal barrier by maintaining tight junction complex and modulating inflammatory response","volume":"104","author":"Zong","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2019.09.001","article-title":"Emerging and reemerging infectious diseases: global overview","volume":"33","author":"Zumla","year":"2019","journal-title":"Infect Dis Clin North Am"},{"key":"B77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00841-7","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-05522-2","article-title":"The WHO estimates of excess mortality associated with the COVID-19 pandemic","volume":"613","author":"Msemburi","year":"2023","journal-title":"Nature"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14102111","article-title":"Lactoferrin binding to SARS-coV-2 spike glycoprotein blocks pseudoviral entry and relieves iron protein dysregulation in several in vitro models","volume":"14","author":"Cutone","year":"2022","journal-title":"Pharmaceutics"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104136","article-title":"Identified human breast milk compositions effectively inhibit SARS-coV-2 and variants infection and replication","volume":"25","author":"Lai","year":"2022","journal-title":"iScience"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2021.1932607","article-title":"Hypoxia reduces cell attachment of SARS-coV-2 spike protein by modulating the expression of ACE2, neuropilin-1, syndecan-1 and cellular heparan","volume":"10","author":"Prieto-Fern\u00e1ndez","year":"2021","journal-title":"Emerg Microbes Infections"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/J.LWT.2021.112684","article-title":"Identification of lactoferrin-derived peptides as potential inhibitors against the main protease of SARS-coV-2","volume":"154","author":"Zhao","year":"2022","journal-title":"LWT"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3390\/PH17081021","article-title":"Lactoferrin binds through its N-terminus to the receptor-binding domain of the SARS-coV-2 spike protein","volume":"17","author":"Babulic","year":"2024","journal-title":"Pharmaceuticals"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/FIMMU.2022.958581\/BIBTEX","article-title":"Blockade of TMPRSS2-mediated priming of SARS-coV-2 by lactoferricin","volume":"13","author":"Ohradanova-Repic","year":"2022","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.992733","article-title":"Lactoferrin for COVID- prevention, treatment, and recovery","volume":"9","author":"Bolat","year":"2019","journal-title":"Fronti Nutr"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph182010985","article-title":"Lactoferrin as antiviral treatment in COVID-19 management: Preliminary evidence","volume":"18","author":"Campione","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/v14061226","article-title":"Mosquito-borne flaviviruses and current therapeutic advances","volume":"14","author":"Qian","year":"2022","journal-title":"Viruses"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1002\/9781119350927.CH33","article-title":"Flaviviruses","author":"Williams","year":"2019","journal-title":"Dis Swine"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3390\/ph10020044","article-title":"Pathogenesis and inhibition of flaviviruses from a carbohydrate perspective","volume":"10","author":"Kim","year":"2017","journal-title":"Pharmaceuticals"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/ph16101385","article-title":"Heparin precursors with reduced anticoagulant properties retain antiviral and protective effects that potentiate the efficacy of sofosbuvir against zika virus infection in human neural progenitor cells","volume":"16","author":"Pagani","year":"2023","journal-title":"Pharmaceuticals"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/v15040860","article-title":"A perspective on current flavivirus vaccine development: A brief review","volume":"15","author":"Dutta","year":"2023","journal-title":"Viruses"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3390\/v13101967","article-title":"Dengue virus infection: A tale of viral exploitations and host responses","volume":"13","author":"Nanaware","year":"2021","journal-title":"Viruses"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/pathogens9110935","article-title":"Molecular changes in dengue envelope protein domain III upon interaction with glycosaminoglycans","volume":"9","author":"Hyatt","year":"2020","journal-title":"Pathogens"},{"key":"B96","unstructured":"Inflammatory mediators in dengue virus infection in children: interleukin-8 and its relationship to neutrophil degranulation\n          \n          \n            \n              Juffrie\n              M\n            \n            \n              van der Meer\n              GM\n            \n            \n              Hack\n              CE\n            \n            \n              Haasnoot\n              K\n            \n            \n              P Veerman\n              AJ\n            \n            \n              Thijs\n              LG\n            \n          \n          \n          2000"},{"key":"B97","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1186\/s12879-016-1759-9","article-title":"Serum neutrophil gelatinase-associated lipocalin and resistin are associated with dengue infection in adults","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Infect Dis"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25081997","article-title":"Viral hepatitis and iron dysregulation: Molecular pathways and the role of lactoferrin","volume":"25","author":"Mancinelli","year":"2020","journal-title":"Molecules"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i38.5759","article-title":"Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma","volume":"26","author":"D\u2019souza","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jinf.2020.01.023","article-title":"Breast milk microbiota: A review of the factors that influence composition","volume":"81","author":"Zimmermann","year":"2020","journal-title":"J Infection"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/FNUT.2022.1033779\/BIBTEX","article-title":"Role of milk glycome in prevention, treatment, and recovery of COVID-19","volume":"9","author":"Kaplan","year":"2022","journal-title":"Front Nutr"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1016\/J.JFF.2019.103485","article-title":"N-glycans from human milk glycoproteins are selectively released by an infant gut symbiont in vivo","volume":"61","author":"Karav","year":"2019","journal-title":"J Funct Foods"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00547-16\/ASSET\/8DFAD725-4DE7-4159-AA5C-9DAEB7283E69\/ASSETS\/GRAPHIC\/ZAM9991171820005.JPEG","article-title":"Oligosaccharides released from milk glycoproteins are selective growth substrates for infant-associated bifidobacteria","volume":"82","author":"Karav","year":"2016","journal-title":"Appl Environ Microbiol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v27.i16.1691","article-title":"From hepatitis A to E: A critical review of viral hepatitis","volume":"27","author":"Castaneda","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1080\/14789450.2017.1344102","article-title":"Hepatitis C virus\u2013apolipoprotein interactions: molecular mechanisms and clinical impact","volume":"14","author":"Crouchet","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/S10989-019-09972-7\/FIGURES\/6","article-title":"A Novel chimeric anti-HCV peptide derived from camel lactoferrin and molecular level insight on its interaction with E2","volume":"26","author":"Tahmoorespur","year":"2020","journal-title":"Int J Pept Res Ther"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.22103\/JAB.2022.18992.1382","article-title":"Comparison of antiviral effect of camel lactoferrin peptide (CLF36) and new generation drugs against hepatitis C virus","volume":"14","year":"2022","journal-title":"Agric Biotechnol J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1402135\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T06:18:14Z","timestamp":1731651494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1402135\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":107,"alternative-id":["10.3389\/fimmu.2024.1402135"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1402135","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"article-number":"1402135"}}